Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Millionaire Makers: 3 Sectors Poised for 20X Gains

Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers.

The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter

Explore why these stocks may explode and could be game-changers in biotechnology, hotels, resorts, cruise lines, and application software.

The Trillion-Dollar Crystal Ball: 3 Companies Next in Line for the Market Milestone

These three companies have the potential to cross over and become the next trillion-dollar stocks—so watch out.

Why Is Geron (GERN) Stock Up 94% Today?

Geron stock is on the rise Friday with heavy trading of GERN shares after the company's blood disorder drug got new backing.

MDGL Stock Alert: The Historic Reason Madrigal Is Up 19% Today

Madrigal Pharmaceuticals stock is up on Friday as MDGL investors celebrate FDA approval of NASH treatment Rezdiffra today.

Why Is LianBio (LIAN) Stock Moving Today?

LianBio stock is incredibly volatile on Friday as heavy trading rocks LIAN amid plans for a voluntary delisting of the shares.

3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold

If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.

High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment

ATNM stock offers moonshot or crash-landing possibilities as Actinium Pharmaceuticals works relentlessly to advance life-changing treatments.

Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024

U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10.

Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging

Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio.

Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?

Spruce Biosciences stock is falling hard on Thursday as investors in SPRB shares react to the latest clinical trial data reported.

Why Is First Wave BioPharma (FWBI) Stock Up Today?

First Wave BioPharma stock is up on Thursday as FWBI investors celebrate the company completing its business combination with ImmunogenX.

7 Delightful Dividend Stocks to Put Some Spring in Your Step

The best dividend stocks can be counted on to give a reliable return to income investors. These seven names are among the best to buy now.

7 Biotech Stocks to Buy as Sector Rotation Ramps Up

While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table…

Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio

One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.

The 3 Most Undervalued Biotech Stocks to Buy in March 2024

 These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March. 

LLY Stock Alert: You Can Now Get Eli Lilly’s Weight Loss Drugs on Amazon

Eli Lilly stock is on the move Wednesday morning as investors in LLY shares learn about a new pharmacy partnership with Amazon!

Why Is NuCana (NCNA) Stock Up 102% Today?

NuCana stock is rising on Wednesday as shares of NCNA experience heavy trading alongside a new patent for the biopharmaceutical company.

7 High-Quality Blue-Chip Stocks to Buy if You’re Looking for Stability

At first glance, a concerted focus on stable blue-chip stocks might seem excessively cautious. After all, the market is booming, companies are hiring and people…